Ryzyko zakażenia pestiwirusami przez stosowanie zanieczyszczonych nimi biopreparatów

• Autorzy: Kesik J. , Larska M. , Zmudzinski J. F.

Warianty tytułu

EN

Risk of pestivirus infection trough contaminated bioproducts

• Języki publikacji: PL

Abstrakty

EN

Contamination of bovine-derived bioproducts with pestiviruses, in particular with bovine viral diarrhea virus, creates a risk of infection for animals and even for humans. Owing to the worldwide spread of pestivirus infections in cattle population, many biological products based on materials derived from cattle or from their tissues are contaminated with this pathogen or contain the viral RNA. Contamination of fetal bovine serum (FBS) by BVDV is an intra-laboratory problem that hinders the diagnostics of infections caused by related viruses, such as classical swine fever virus (CSFV) or hepatitis C (HCV) in humans. Furthermore, vaccines, hormones or other bioproducts used in animals and humans may be contaminated with the virus. The article describes numerous examples of transmission of virulent pestiviruses to susceptible populations through the use of contaminated animal bioproducts.

Słowa kluczowe

PL

biopreparaty; plodowa surowica bydleca; albumina surowicy bydlecej; ekstrakt przysadki mozgowej; kontaminacja; pestiwirusy; wirus biegunki bydla; zanieczyszczenia wirusowe; przenoszenie wirusow

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2015
• Tom: 71
• Numer: 03
• Opis fizyczny: s.131-135,bibliogr.

Twórcy

autor

Kesik J.

• Zakład Wirusologii, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, Al.Partyzantów 57, 24-100 Puławy

autor

Larska M.

• Zakład Wirusologii, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, Al.Partyzantów 57, 24-100 Puławy

autor

Zmudzinski J. F.

• Zakład Wirusologii, Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy w Puławach, Al.Partyzantów 57, 24-100 Puławy

Bibliografia

• 1. Audet S. A., Crim R. L., Beeler J.: Evaluation of vaccines, interferons and cell substrates for pestivirus contamination. Biologicals. 2000, 28, 41-46.
• 2. Azar Daryany M. K., Hosseini S. M., Raie M., Fakharie J., Zareh A.: Study on continuous (254 nm) and pulsed UV (266 and 355 nm) lights on BVD virus inactivation and its effects on biological properties of fetal bovine serum.J. Photochem. Photobiol. B. 2009, 94, 120-124.
• 3. Barkema H. W., Bartels C. J., Wuijckhuise L., van Hesselink J. W., Holzhauer M., Weber M. F., Franken P., Kock P. A., Bruschke C. J., Zimmer G. M.: Outbreak ofbovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1marker vaccine contaminated with bovine virus diarrhea virus type 2. Tijdschr.Diergeneeskd. 2001, 126, 158-165.
• 4. Bauermann F. V., Flores E. F., Falkenberg S. M., Weiblen R., Ridpath J.: Lack of evidence for the presence of emerging HoBi-like viruses in North American fetal bovine serum lots. J Vet Diagn Invest. 2014. DOI: 10.1177/1040638713518208
• 5. Bielański A., Algire J., Lalonde A., Nadin-Davis S.: Transmission of bovine viral diarrhea virus (BVDV) via in vitro-fertilized embryos to recipients, butnot to their offspring. Theriogenology 2009, 71, 499-508.
• 6. Bolin S. R., Ridpath J. F., Black J., Macy M., Roblin R.: Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. J. Virol.Methods. 1994, 48, 211-221.
• 7. Decaro N., Lucente M. S., Mari V., Cirone F., Cordioli P., Camero M., Sciarretta R., Losurdo M., Lorusso E., Buonavoglia C.: Atypical pestivirusand severe respiratory disease in calves, Europe. Emerg Infect Dis. 2011, 17,1549-1552.
• 8. Decaro N., Mari V., Lucente M. S., Sciarretta R., Elia G., Ridpath J. F., Buonavoglia C.: Detection of a Hobi-like virus in archival samples suggests circulation of this emerging pestivirus species in Europe prior to 2007. Vet. Microbiol. 2013, 167, 307-313.
• 9. Falcone E., Cordioli P., Tarantino M., Muscillo M., Sala G., La Rosa G., Archetti I. L., Marianelli C., Lombardi G., Tollis M.: Experimental infection of calveswith bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminatedvaccine. Vet. Res Commun. 2003, 27, 577-589.
• 10. Falcone E., Tollis M., Conti G.: Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 1999, 18, 387-388.
• 11. Fan X. Z., Ning Y. B., Wang Q., Xu L., Shen Q. C.: Detection of bovine viral diarrhea virus as contaminant in classical swine fever virus live vaccine withRT-PCR. Chin. J. Vet. Med. 2010, 46, 8-10.
• 12. Farmakopea Polska. Wyd. IX, t. I, Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, Warszawa 2011,645-655, 801-806, 820-827.
• 13. Giangaspero M., Vacirca G., Buettner M., Wolf G., Vanopdenbosch E., Muyldermans G.: Serological and antigenical findings indicating pestivirus inman. Arch. Virol. Suppl. 1993, 7, 53-62.
• 14. Giangaspero M., Vacirca G., Morgan D., Baboo K. S., Luo N. P., DuPont H. L., Zumla A.: Anti-bovine viral diarrhoea virus antibodies in adult Zambian patientsinfected with the human immunodeficiency virus. Int J STD & AIDS 1993, 4,300-302.
• 15. Gilliland S. M., Forrest L., Carre H., Jenkins A., Berry N., Martin J., Minor P., Schepelmann S.: Investigation of porcine circovirus contamination in humanvaccines. Biologicals. 2012, 40, 270-277.
• 16. Givens M. D., Waldrop J. G.: Bovine viral diarrhea virus in embryo and semen production systems. Vet. Clin. North Am. Food Anim. Pract. 2004, 20, 21-38.
• 17. Gregg K., Chen S. H., Sadeghieh S., Guerra T., Xiang T., Meredith J., Polejaeva I.: Experimental risk assessment of bovine viral diarrhea virustransmission via in vitro embryo production using somatic cell nucleus transfer.Theriogenology 2009, 72, 99-110.
• 18. Harasawa R.: Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Vaccine 1995, 13, 100-103.
• 19. Harasawa R., Sasaki T.: Sequence analysis of the 5’ untranslated region of pestivirus RNA demonstrated in interferons for human use. Biologicals. 1995,23, 263-269.
• 20. Harasawa R., Tomiyama T.: Evidence of pestivirus RNA in human virus vaccines. J. Clin. Microbiol. 1994, 32, 1604-1605.
• 21. Jensen M. H.: Hog cholera antibodies in pigs vaccinated with an Aujeszky- vaccine based on antigen produced in IB-RS-2 cells. Acta Vet. Scand. 1991, 22, 517-523.
• 22. Kozasa T., Aoki H., Nakajima N., Fukusho A., Ishimaru M., Nakamura S.: Methods to select suitable fetal bovine serum for use in quality control assaysfor the detection of adventitious viruses from biological products. Biologicals.2011, 39, 242-248.
• 23. Kulcsár G., Soós P., Kucsera L., Glávits R., Pálfi V.: Patogenicity of a bovine viral diarrhoea virus strain in pregnant sows: short comunication. Acta Vet. Hung. 2001, 49, 117-120.
• 24. Larska M., Kuta A., Polak M. P.: Evaluation of diagnostic methods to distinguish between calves persistently and transiently infected with bovine viral diarrhoeavirus in respect to the presence of maternal antibodies. Bull. Vet. Inst. Pulawy2013, 57, 311-317.
• 25. Løken T., Krogsrud J., Bjerkås I.: Outbreaks of border disease in goats induced by a pestivirus-contaminated orf vaccine, with virus transmission to sheep and cattle. J. Comp. Pathol. 1991, 104, 195-209.
• 26. Makoschey B., Gelder P. T. van, Keijsers V., Goovaerts D.: Bovine viral diarrhea virus antigen in foetal calf serum batches and consequences of such contaminationfor vaccine production. Biologicals. 2003, 31, 203-208.
• 27. Nims R. W., Gauvin G., Plavsic M.: Gamma irradiation of animal sera for inactivation of viruses and mollicutes – a review. Biologicals. 2011, 39, 370-377.
• 28. Polak M. P., Rola J., Żmudziński J. F.: Contamination of foetal bovine serum with bovine viral diarrhoea virus (BVDV). Bull. Vet. Inst. Pulawy 2008, 52,501-505.
• 29. Stacey G., Davis J.: Medicines from Animal Cell Culture. John Wiley&Sons Ltd, England 2007, s. 46-56.
• 30. Ståhl K., Beer M., Schirrmeier H., Hoffmann B., Belák S., Alenius S.: Atypical ‘HoBi’-like pestiviruses – Recent findings and implications thereof. VeterinaryMicrobiology 2010, 21, 90-93.
• 31. Studer E., Bertoni G., Candrian U.: Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals. 2002, 30, 289-296.
• 32. Tao J., Liao J., Wang Y., Zhang X., Wang J., Zhu G.: Bovine viral diarrhea virus (BVDV) infections in pigs. Veterinary Microbiology 2013, 165, 185-189.
• 33. Tao J., Wang Y., Wang J., Zhou H., Li Y. L., Zhu G. Q.: Identivication of bovine viral diarrhea virus 2 from classical swine fever vaccine. Chin. J. Prev. Vet.Med. 2012, 34, 581-583.
• 34. Trachte E., Stringfellow D., Riddell K., Galik P., Riddell M. Jr, Wright J.: Washing and trypsin treatment of in vitro derived bovine embryos exposed tobovine viral diarrhea virus. Theriogenology 1998, 50, 717-726.
• 35. Uryvaev L. V., Dedova A. V., Dedova L. V., Ionova K. S., Parasjuk N. A., Selivanova T. K., Bunkova N. I., Gushina E. A., Grebennikova T. V., Podchernjaeva R. J.: Contamination of cell cultures with bovine viral diarrheavirus (BVDV). Bull. Exp. Biol. Med. 2012, 153, 77-81.
• 36. Vannier P., Leforban Y., Carnero R., Cariolet R.: Contamination of a live virus vaccine against pseudorabies (Aujeszky’s disease) by an ovine pestivirus pathogen for the pig. Ann. Rech. Vet. 1988, 19, 283-290.
• 37. Vilcek S., Paton D. J., Minor P., Bentley M.: No confirmation of pestivirus RNA in human virus vaccines. J. Clin. Microbiol. 1999, 37, 1653.
• 38. Wensvoort G., Terpstra C.: Bovine viral diarrhoea virus infections in piglets born to sows vaccinated against swine fever with contaminated vaccine. Res.Vet. Sci. 1988, 45, 143-148.
• 39. Wessman S. J., Levings R. L.: Collective experiences of adventitious viruses of animal-derived raw materials and what can be done abort them. Cytotechnology1998, 28, 43-48.
• 40. Wuijckhuise L. van, Frankena K., van Oijen M. A., Meijer L.: Analysis of symptoms associated with bovine herpesvirus 1 vaccination. Tijdschr Diergeneeskd.2001, 126 (6), 173-180.
• 41. Xia H., Larska M., Giammarioli M., De Mia G. M., Cardeti G., Zhou W., Alenius S., Belák S., Liu L.: Genetic detection and characterization of atypical bovine pestiviruses in foetal bovine sera claimed to be of Australian origin.Transbound. Emerg. Dis. 2013, 60, 284-288.
• 42. Yanagi M., Bukh J., Emerson S. U., Purcell R. H.: Contamination of commercially available fetal bovine sera with viral diarrhea virus genomes: implicationfor the study of hepatitis C virus in cell culture. J. Infect. Dis. 1996, 174, 1324--1327.
• 43. Yolken R., Dubovi E., Leister F., Reid R., Almeido-Hill J., Santosham M.: Infantile gastroenteritis associated with excretion of pestivirus antigens. Lancet1989, 1, 517-520.
• 44. Zanotto C., Giangaspero M., Büttner M., Braun A., Morghen C. G., Elli V., Panuccio A., Radaelli A.: Evaluation of poliovirus vaccines for pestivirus contamination:non-specific amplification of poliovirus sequences by pan-pestivirusprimers. J. Virol. Methods 2002, 102, 167-172.